Cancer Research UK and Immatics Biotechnologies Launch Trial for Brain Cancer Vaccine
Cancer Research UK and Cancer Research Technology - the charity's development and commercialisation arm - together with immatics biotechnologies have launched the first clinical trial of a promising cancer vaccine to treat glioblastoma, one of the most common forms of brain cancer.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.